Current Ratio: Definition, Formula, Meaning, Examples, Accounting

Subscribe to newsletter

When it comes to the financial health of a company, the current ratio is one of the most important indicators to look at. This ratio measures a company’s ability to pay its short-term obligations with its current assets. In other words, it shows how well a company can pay off its debts if they all came due today.

Investors and lenders often use the current ratio to get a quick sense of whether a company is in financial trouble. In this article, we’ll discuss what the current ratio is, a few examples, and how it is used in accounting. So if you are interested in learning more about this important financial metric, read on.

What is the current ratio?

The current ratio is a liquidity measure that assesses a firm’s capacity to pay short-term debts such as bills that are due in one year. This report explains how a firm can increase current assets on its balance sheet to meet existing debt and other payables.

Subscribe to newsletter https://harbourfrontquant.beehiiv.com/subscribe Newsletter Covering Trading Strategies, Risk Management, Financial Derivatives, Career Perspectives, and More

Most businesses consider a current ratio that is in line with the industry average or slightly higher to be acceptable. A current ratio lower than the industry average indicates that the company may have difficulty paying its short-term obligations. Similarly, a current ratio that is much higher than the average may suggest that the company is not efficiently using its assets.

How to calculate the current ratio

The current ratio is calculated by dividing a company’s total current assets by its total current liabilities.

So the formula to calculate the current ratio would look like this

Current Ratio = Current Assets / Current Liabilities

For example, let’s say that ABC Company has $1,000 in cash, $500 in accounts receivable, and $200 in inventory. Their total current assets would be $1,700. If they have $1,000 in accounts payable and $300 in short-term debt, their total current liabilities would be $1,300. Therefore, their current ratio would be 1.7.

($1,700 in current assets / $1,300 in current liabilities).

Examples used in accounting

The current ratio is one of the most important ratios in accounting and is used to assess a company’s financial health. As this ratio measures a company’s ability to pay its short-term obligations with its current assets, it provides insight into whether a company will be able to meet its financial obligations in the event of an emergency.

Let’s say a company that has $10,000 in cash, $5,000 in accounts receivable, and $2,000 in inventory. Their total current assets would be $17,000. If they have $9,000 in accounts payable and $4,000 in short-term debt, their total current liabilities would be $13,000. Therefore, their current ratio would be 1.3

In this example, the company’s current ratio is below the industry average, which may suggest that the company is in financial trouble. However, it is important to note that the current ratio is just one metric and should not be used as the sole indicator of a company’s financial health.

Conclusion

As you can tell by now, the current ratio is a very important financial metric. It is used to assess a company’s ability to pay its short-term obligations with its current assets and provides insight into the overall financial health of a company. If you are interested in investing in a company or lending them money, the current ratio is one of the first things you should look at.

Subscribe to newsletter https://harbourfrontquant.beehiiv.com/subscribe Newsletter Covering Trading Strategies, Risk Management, Financial Derivatives, Career Perspectives, and More

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSMediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
Stay up-to-date with the latest news - click here
LATEST NEWSTortoise Capital Announces Shareholder Approval of Closed-End Fund Mergers and Conversion to Actively Managed ETF
Tortoise Capital Announces Shareholder Approval of Closed-End Fund Mergers and Conversion to Actively Managed ETF
Stay up-to-date with the latest news - click here
LATEST NEWSU. S. Steel Reacts to Important Department of Commerce Preliminary Results
U. S. Steel Reacts to Important Department of Commerce Preliminary Results
Stay up-to-date with the latest news - click here
LATEST NEWSAlkermes' chief medical officer sells $290,461 in stock
Alkermes' chief medical officer sells $290,461 in stock
Stay up-to-date with the latest news - click here
LATEST NEWSNatural Grocers exec Isely Lark sells $178,640 in stock
Natural Grocers exec Isely Lark sells $178,640 in stock
Stay up-to-date with the latest news - click here

Leave a Reply